Status:

COMPLETED

Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer

Lead Sponsor:

North Florida/South Georgia Veterans Health System

Collaborating Sponsors:

North Florida Foundation for Research and Education

Axcan Pharma

Conditions:

Superficial Bladder Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

This protocol is evaluating efficacy and toxicity of three sequential whole bladder photodynamic treatment with Photofrin and red laser light (630 nm) in the management of superficial bladder cancer (...

Detailed Description

Patient Evaluation and Treatment: 1. Patients will sign an IRB-approved informed consent form 2. Initial patient assessments will include: * eligibility * History and physical. * clinical p...

Eligibility Criteria

Inclusion

  • Pathological diagnosis of bladder cancer, non muscle invasive
  • Recurrent after at least one course of standard intravesical therapy after transurethral resection (TURBT).
  • Maximum debulking of tumor by TURBT/fulguration
  • One or more of the following:
  • Contraindications to conventional intravesical therapy, including patient's refusal.
  • Positive or suspicious urine cytology localized to the bladder
  • Prior intravesical therapy and persistent atypia.
  • Premalignant (diffuse squamous metaplasia or malakoplakia) lesions.
  • Bladder capacity greater or equal to 150 cc.
  • No contraindications to an appropriate anesthesia or analgesia.
  • Karnofsky's performance status \> 50.
  • Patients must sign an informed consent form in accordance with the Institution's Review Board and FDA 21 CFR Part 50.
  • Female patients must be practicing a medically acceptable form of birth control or be sterile or postmenopausal.

Exclusion

  • Pregnant or nursing mother.
  • Known hypersensitivity to porphyrins.

Key Trial Info

Start Date :

February 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2011

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT00322699

Start Date

February 1 2005

End Date

March 1 2011

Last Update

October 26 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Malcom Randall NF/SG Veterans Administration Health System

Gainesville, Florida, United States, 32608